GSK · SUB~ · EC · MINISTERIO DE SALUD PUBLICA MATRIZ

Why it is here

Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 3 non-competitive contracts at the buyer «MINISTERIO DE SALUD PUBLICA MATRIZ», 153,252 USD (≈ $153,252); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20260002969204-2455, ocds-5wno2w-CE-20260002969248-2455, ocds-5wno2w-CE-20260002969254-2455; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).

Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.

Details

Company / subject

GSK · SUB~ · EC · MINISTERIO DE SALUD PUBLICA MATRIZ

Indicator

Debarred / sanctioned abroad × US SEC issuer

Amount

153,252

Records behind the indicator

3

Found

4 October 2026

Code

W-02872

Reference

SICM-366-2022-A

Reference

ocds-5wno2w-CE-20260002969204-2455

Reference

ocds-5wno2w-CE-20260002969248-2455

Reference

ocds-5wno2w-CE-20260002969254-2455